MiR‐138‐5p, which decreased in CRC tissues, could inhibit cell migration and chemoresistance in CRC by targeting the nuclear factor I/B (NFIB)‐Snail1 axis.67 This evidence concerns the gene NFIB and colorectal carcinoma.